MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development28 Apr 2019
Provides a guide on all aspects of the subject with much of the information based on the systems, processes and expertise built up at MedPharm.
MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: The Art and Science of Dermal Formulation Development. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
The Art and Science of Dermal Formulation Development provides a comprehensive guide to all aspects of the subject, from the structure of skin and formulation development and performance testing to the chemical, physical and technological modulation of delivery and manufacturing processes.
Professor Brown said: “The book covers early-stage preformulation and formulation development right through to product manufacture. Much of the information is based on the systems, processes and expertise we have built up at MedPharm over the years and which have successfully led to the commercial launch of over 50 products by our clients.
The global pharmaceutical dermatology market was valued at $52 billion in 2018 and has been predicted to double over the next 10 years. Patients and consumers of OTC products globally are demanding higher standards of treatment from products which are easy to use and which help compliance.
Prof. Brown continued: “The demand within the pharmaceutical industry for these specialised and complex development services continues to grow as more becomes known about the important biochemical process occurring in the skin. This shift within the industry has been reflected in the expanding demand for MedPharm’s services.”
Prior to co-founding MedPharm in 1999 and throughout his time at the company, Professor Brown has held full, part-time or visiting academic positions at several UK universities. Both Professors have co-authored over 300 research and technical publications and supervised over 100 graduate students in the field.
Dr Jon Lenn, MedPharm CTO added “The book provides an in-depth and coherent introduction to the discipline of topical and transdermal product development for the scientific community.
He continued: “We are very pleased to be able to promote the science behind what we do. Innovating and ensuring we continue to develop our scientific expertise has been crucial and will remain fundamental to MedPharm’s future growth and support for its customers.”
New microbial air sampler addresses continuous monitoring
14 Nov 2019
The device supports the new EU GMP Annex 1 requirements.Read more
GVK Bio continues to see growth tailwinds for 2020 thanks to a ‘crescendo of factors’
13 Nov 2019
China-US trade challenges has led to de-risking by pharma companies.Read more
Winners of the 16th Pharma Awards
11 Nov 2019
Companies and individuals from across the whole pharma supply chain recognised for their excellence and commitment.Read more
CDMOs to benefit from rising BTDs, orphan drugs and fast track status therapies
8 Nov 2019
But personalized medicines will require new logistics and manufacturing systems.Read more
SGH Healthcaring unveils its new asthma spacer device
8 Nov 2019
Zephyr's revolutionary new design improves drug administration and simplifies treatment delivery for better observance.Read more
Recipharm expands Indian injectable dosage form capabilities
7 Nov 2019
Partnership will combine capabilities and expertise in Europe and India to build a new facility dedicated to injectable formulations to supply demand from Europe and overseas territories.Read more
Aptar acquires a leader in drug delivery training devices and patient onboarding
6 Nov 2019
Acquisition reflects movement of treatments being administered by patients at home rather than by healthcare providers.Read more
Europe predicted to surpass the US in biologic manufacturing capacity by 2023
6 Nov 2019
Demand for biological manufacturing is growing faster than capacity growth.Read more
SP acquires Spain based global provider of complete sterile filling lines
5 Nov 2019
Company's strategic move reflects its expectation of short-run aseptic liquid filling to continue to drive pharmaceutical growth.Read more
Legacy recruits heavily to meet growing steriles demand
5 Nov 2019
Company to reach 250 employees by year end to meet growing drug product manufacturing demand.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation